Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool September 21, 2006 Brian Lawler	ImClone's Board Shakeup A new face in the boardroom heralds change for the troubled company. Shareholders yesterday elected notorious corporate raider Carl Icahn to the company's board of directors.
The Motley Fool September 1, 2009 Rick Aristotle Munarriz	Icahn Handles the Truth at Yahoo! Carl Icahn has sold shares of struggling online giant Yahoo! in each of the past three trading days, enough to take his stake below 5%.
Search Engine Watch August 6, 2008 Kevin Ryan	Woohoo for Yahoo Even after the vote re-count, a majority of shareholders voted Yahoo's board in, and Carl Icahn settled for the right to propose two board seats and a spot for himself. At the end of the day, what's more important than rebuilding the Web's biggest brand?
The Motley Fool July 8, 2008 Rick Aristotle Munarriz	Doesn't Yahoo! Get a Say? Billionaire investor Carl Icahn and Microsoft insist that only a new boardroom -- ideally populated by the slate of directors that Icahn is proposing -- will lead Microsoft to reopen acquisition talks with Yahoo!.
The Motley Fool January 18, 2012 Dawn Kawamoto	Yahoo!'s Yang Out, Board Selection Trumps New CEO Selection Yahoo! is reportedly on the prowl for new board directors, as shareholder activist Third Point LLC is increasing pressure to name its own competing slate.
InternetNews July 20, 2009	Icahn Pushing Again for Yahoo-Microsoft Deal Carl Icahn, the billionaire investor who made so much trouble for Yahoo last year, has spoken out in favor of a deal with Microsoft, which reportedly could be announced as early as this week.
The Motley Fool September 15, 2011 Dawn Kawamoto	Reshuffling Yahoo!'s Board: A New House of Cards? It may take an activist shareholder to bring about meaningful change.
InternetNews February 28, 2008 Kenneth Corbin	Shareholders Blast Yahoo Over Microsoft Bid Yahoo said that seven shareholder groups have filed lawsuits against the company's board of directors since Microsoft announced its unsolicited bid to take over the company.
The Motley Fool May 15, 2008 Rick Aristotle Munarriz	Bored of Directors at Yahoo! Carl Icahn has Yahoo!'s board in his crosshairs.
InternetNews March 24, 2008	Icahn Sues Motorola to Get Access to Documents Investor Carl Icahn said on Monday he is suing Motorola to force it to hand over documents related to its mobile devices business, and he urged investors to elect his slate of candidates to the Motorola board.
The Motley Fool February 8, 2005 Tom Taulli	Retro Raider Strikes Again Carl Icahn has been very busy lately -- and his most recent prey is cardboard packaging manufacturer Temple-Inland. The stock closed unchanged yesterday at $75.75. It had surged 16% when his interest in the stock became public.
InternetNews March 24, 2008 Judy Mottl	Icahn Challenges Motorola on Handheld Strategy Motorola stockholder and longtime critic Carl Icahn is seeking answers about the company's floundering performance, filing a lawsuit today seeking documents related to Moto's beleaguered mobile device division.
The Motley Fool September 11, 2008 Brian Orelli	Vive le Vioxx Lawsuit Just when Merck thought it was finally done with lawsuits pertaining to Vioxx, it's gotten pulled back in.
The Motley Fool October 4, 2006 Brian Lawler	Unwelcome Guests at ImClone ImClone's board of directors votes against Carl Icahn's proposed removal of six company directors. Short-term shareholders that are able to cash out with Icahn, will possibly have a nice gain to take home.
The Motley Fool July 29, 2008 Rick Aristotle Munarriz	Pickens Nitpicks Yahoo! Billionaire investor Pickens is digging into the top brass at Yahoo! this week, after bailing on his investment in the Internet portal at a loss.
The Motley Fool July 23, 2008 Rick Aristotle Munarriz	Icahn's Spotty Track Record Carl Icahn and Yahoo! have made nice, in advance of next week's meeting, but will the peace last? Or is the current calm just the eye of the hurricane?
The Motley Fool April 30, 2007 Tom Taulli	Proxy Fights 101 How shareholder skirmishes are transforming Wall Street. It's smart to understand how proxy fights work, but don't assume they're a good system for investing. Proxy battles often target struggling companies with volatile stocks.
The Motley Fool October 14, 2011 Dawn Kawamoto	Jaguar Could Bag Research In Motion Soon Jaguar Financial has enough support from disgruntled investors to call a special meeting in the next three months to oust RIM's entire board of directors.
The Motley Fool January 30, 2009 Brian Orelli	Icahn's Next Target Activist investor Carl Icahn has decided to nominate a slate of five directors for the board of Amylin Pharmaceuticals, of which he owns 8.3%.
The Motley Fool May 16, 2008 Mac Greer	Fool Video: Icahn Bares His Teeth, Craig's Cyst, and 5 Stocks Approaching Greatness Can Craigslist delete eBay? Will Icahn deliver for Microsoft? These questions are discussed in this video.
InternetNews March 5, 2008	Yahoo Buys Some Breathing Room Yahoo extended its deadline to nominate board directors, gaining time to seek alternatives or negotiate friendlier terms to a $41.7 billion buyout offer from Microsoft.
The Motley Fool November 4, 2005 Rich Duprey	Merck Eases Its Pain The pharmaceutical giant wins an important Vioxx trial. And while it's a welcome reprieve for the company, the decision doesn't seem to warrant the enthusiasm with which the market greeted the decision.
BusinessWeek March 5, 2007 Ronald Grover	Just Don't Call Him A Raider Carl Icahn, who now styles himself a shareholder activist, prepares for battle with Motorola.
The Motley Fool August 1, 2008 Brian Lawler	Is $60 a Share Enough for ImClone? Bristol-Myers Squibb announced a $60-per-share offer for ImClone Systems, but are shareholders going to go for the deal?
The Motley Fool November 13, 2007 Brian Orelli	Merck: Case Closed? Now that Merck has settled its lawsuit, it can get back to business, focusing on continued growth from its cholesterol drugs, new diabetic medication, and cervical cancer vaccine. Investors, take note.
The Motley Fool June 17, 2008 Anders Bylund	Icahn, the Turncoat Who cares why he changed his position about Yahoo?'s board? Just be happy that he did.
The Motley Fool June 26, 2008 Rick Aristotle Munarriz	From Yahoo! With Love Yahoo!'s CEO reaches out to shareholders with an update. They wanted answers. Unfortunately, they're only walking away with even more questions.
The Motley Fool May 23, 2008 Rick Aristotle Munarriz	Board Games at Yahoo! Investors don't need to wait until to July to shake up the Yahoo! board. One member is stepping down now.
The Motley Fool April 16, 2009 Brian Orelli	Icahn: Ludicrous and Arrogant Fun to read, but does he have the best intentions for long-term shareholders?
Search Engine Watch June 11, 2008 Kevin Ryan	Carl Icahn Can't Save Yahoo Last week's public exchange between Icahn and Yahoo management is just the latest round of treating symptoms while ignoring the illness.
The Motley Fool June 4, 2009 Brian Orelli	Ignore Icahn's Hoopla Carl Icahn and his fights with management at Biogen's Idec make for entertaining news coverage, but investors shouldn't spend too much time analyzing how the antics are going to affect the share price.
The Motley Fool October 12, 2005 W.D. Crotty	Icahn's Case for Time Warner Carl Icahn issues an open letter to shareholders pushing for change on the company's board. Investors should realize, though, that just because Icahn is around, that doesn't mean their shares will automatically go up.
BusinessWeek September 5, 2005 Amy Barrett	The Pain Is Just Beginning Why the Vioxx debacle will hobble Merck for years to come
The Motley Fool April 21, 2005 Timothy M. Otte	Brawling at Blockbuster What's with this war of words between corporate raider Carl Icahn and Blockbuster management?
The Motley Fool June 4, 2008 Rick Aristotle Munarriz	Yahoo! Casts a Wider Net Yahoo! announces several new deals, including two with Wal-Mart and CBS, all geared toward broadening the company's advertising reach.
The Motley Fool April 3, 2006 Rich Duprey	Merck Outclassed Class action status is granted to third parties -- like health insurance companies, HMOs, and unions -- in a Vioxx lawsuit. Investors, this is a disturbing development.
The Motley Fool August 2, 2007 Brian Orelli	98 Lawsuits Down, About 15,000 To Go Merck's Vioxx caseload just got a little smaller, when an appellate court ruled that 98 people from England and Wales could not sue in the U.S. Shares are up on the news.
The Motley Fool June 16, 2010 Ryan McBride	Genzyme Annual Meeting Remarkably Mundane, Despite Rocky Year Genzyme's annual meeting was over in about an hour, and although the company took some hard questions from a shareholder, it appears that chairman and CEO Henri Termeer and the rest of the company's directors were easily reelected to serve on the board of directors.
BusinessWeek March 6, 2006 Ronald Grover	Carl Icahn: Still An Improbable Robin Hood Carl Icahn is out to recast himself as the hedge fund investor's champion. That image has its critics.
InternetNews January 30, 2007 Ed Sutherland	Icahn Has Motorola in His Sites News Wall Street trader Carl Icahn wants a spot on Motorola's board sent tongues wagging and stock prices up.
InternetNews March 26, 2008	Motorola to Split Into Two Motorola said on Wednesday it would split into two publicly traded entities to separate its loss-making handset division from its other businesses.
InternetNews April 7, 2008 Kenneth Corbin	Yahoo Calls Microsoft Out on Bid Ultimatum Yahoo fires back at Microsoft for its 'counterproductive' letter threatening a proxy fight.
The Motley Fool April 10, 2006 Rich Duprey	Merck Splits the Difference The pharmaceutical wins one, loses one in New Jersey Vioxx trials. Investors should expect to see more losses.
The Motley Fool January 29, 2010 Brian Orelli	Icahn Back to Batter Biogen The old guy has tenacity.
The Motley Fool June 11, 2008 Brian Lawler	He Said, Biogen Said Pharmaceutical Biogen Idec's battle with Carl Icahn is coming to a head.
The Motley Fool March 23, 2010 Brian Orelli	Icahn and Biogen Kiss and Make Up He gets one more seat on the board, so what's next?
The Motley Fool June 22, 2011	Here's What Carl Icahn Bought and Sold Last Quarter A look under the hood at what Carl Icahn was up to in the first three months of 2011.
The Motley Fool February 17, 2010 Anders Bylund	Who Is Icahn Selling To Now? Lionsgate is looking to buy the Miramax studio from Walt Disney in what looks like a good stylistic match. Will Carl Icahn turn the tables on that deal and coax a bid out of Disney?
The Motley Fool February 23, 2010 Brian Orelli	Icahn Puts His Proxy Fight Where His Money Is How patient will Carl Icahn be with Genzyme's turnaround plan? That's the $270 million question -- the value of Icahn's shares, based on his holdings at the end of the year.
InternetNews February 20, 2008 Kenneth Corbin	Yahoo's Severance Plans a Defense Against Microsoft? Generous compensation packages at Yahoo would provide for workers lost in the upheaval of a takeover.